-
1
-
-
0027373318
-
Reducing chemotherapy-induced nausea and vomiting
-
Del Favero A, Roila F, Tonato M: Reducing chemotherapy-induced nausea and vomiting. Drug Saf 9:410-428, 1993
-
(1993)
Drug Saf
, vol.9
, pp. 410-428
-
-
Del Favero, A.1
Roila, F.2
Tonato, M.3
-
2
-
-
0024515648
-
Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin
-
Kris MG, Gralla RJ, Tyson LB, et al: Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7:108-112, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 108-112
-
-
Kris, M.G.1
Gralla, R.J.2
Tyson, L.B.3
-
3
-
-
0026741005
-
Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients
-
Moreno I, Rosell R, Abad A, et al: Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer 28A:1344-1347, 1992
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 1344-1347
-
-
Moreno, I.1
Rosell, R.2
Abad, A.3
-
4
-
-
0027998873
-
Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cycles
-
Italian Group for Antiemetic Research: Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cycles. Ann Oncol 5:585-589, 1994
-
(1994)
Ann Oncol
, vol.5
, pp. 585-589
-
-
-
5
-
-
0023750516
-
Oral metoclopramide with or without diphenhydramine: Potential for the prevention of late nausea and vomiting induced by cisplatin
-
Grunberg SM, Ehler E, McDermed JE, et al: Oral metoclopramide with or without diphenhydramine: Potential for the prevention of late nausea and vomiting induced by cisplatin. J Natl Cancer Inst 80:864-868, 1988
-
(1988)
J Natl Cancer Inst
, vol.80
, pp. 864-868
-
-
Grunberg, S.M.1
Ehler, E.2
McDermed, J.E.3
-
6
-
-
0029102865
-
Oral ondansetron for the control of cisplatin-induced delayed emesis: A large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo
-
Navari RM, Madajewicz S, Anderson N, et al: Oral ondansetron for the control of cisplatin-induced delayed emesis: A large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo. J Clin Oncol 13:2408-2416, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 2408-2416
-
-
Navari, R.M.1
Madajewicz, S.2
Anderson, N.3
-
7
-
-
0000526011
-
Preventing nausea and vomiting during days 2-7 following high-dose cisplatin chemotherapy. A study by the National Cancer Institute of Canada Clinical Trials Group
-
abstr 1745
-
Johnston D, Latreille J, Laberge F, et al: Preventing nausea and vomiting during days 2-7 following high-dose cisplatin chemotherapy. A study by the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 14:529, 1995 (abstr 1745)
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 529
-
-
Johnston, D.1
Latreille, J.2
Laberge, F.3
-
8
-
-
0028806051
-
Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis
-
Italian Group for Antiemetic Research: Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Ann Oncol 6:805-810, 1995
-
(1995)
Ann Oncol
, vol.6
, pp. 805-810
-
-
-
10
-
-
0000668906
-
New approaches in preventing delayed emesis: Altering the time of regimen initiation and use of combination therapy in a 109 patient trial
-
abstr 1731
-
Rittemberg CN, Gralla RJ, Lettow LA, et al: New approaches in preventing delayed emesis: Altering the time of regimen initiation and use of combination therapy in a 109 patient trial. Proc Am Soc Clin Oncol 14:526, 1995 (abstr 1731)
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 526
-
-
Rittemberg, C.N.1
Gralla, R.J.2
Lettow, L.A.3
|